MNAC13 is a chimeric mouse IgG1 antibody targeting human TrkA. By specifically binding to the TrkA receptor, MNAC13 inhibits NGF-dependent signaling pathways. It demonstrates effective and lasting analgesic properties, making MNAC13 suitable for research on inflammation and chronic pain.
Target:
Trk receptor
* VAT and and shipping costs not included. Errors and price changes excepted
